Jordi Puig

4.4k total citations
102 papers, 2.3k citations indexed

About

Jordi Puig is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Jordi Puig has authored 102 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Infectious Diseases, 46 papers in Virology and 40 papers in Emergency Medicine. Recurrent topics in Jordi Puig's work include HIV Research and Treatment (46 papers), HIV/AIDS drug development and treatment (42 papers) and HIV-related health complications and treatments (40 papers). Jordi Puig is often cited by papers focused on HIV Research and Treatment (46 papers), HIV/AIDS drug development and treatment (42 papers) and HIV-related health complications and treatments (40 papers). Jordi Puig collaborates with scholars based in Spain, Italy and Canada. Jordi Puig's co-authors include Bonaventura Clotet, Eugènia Negredo, Núria Pérez‐Álvarez, Anna Bonjoch, Julià Blanco, Marta Massanella, Patricia Echeverría, Carla Estany, José Moltó and Adolfo Díez‐Pérez and has published in prestigious journals such as Nature Communications, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Jordi Puig

98 papers receiving 2.2k citations

Peers

Countries citing papers authored by Jordi Puig

Since Specialization

Citations

This map shows the geographic impact of Jordi Puig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Puig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Puig more than expected).

Fields of papers citing papers by Jordi Puig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordi Puig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Puig. The network helps show where Jordi Puig may publish in the future.

Co-authorship network of co-authors of Jordi Puig

This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Puig. A scholar is included among the top collaborators of Jordi Puig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Puig. Jordi Puig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)—a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol 2025 ·BMJ Open ·Eugènia Negredo, (unknown), (unknown), Vicenç Falcó, Àngel Rivero, (unknown), (unknown), (unknown), Juliessa M. Pavon, (unknown), (unknown), (unknown), (unknown), Lucía Bailón, Daniel Aguilar, Francis Ruiz, Cristina Miranda, Jordi Puig, (unknown), Julián Olalla	0
2	Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population 2024 ·International Journal of Molecular Sciences ·Cora Loste, (unknown), (unknown), Víctor Urrea, Ana Raquel Ortega Martínez, Sandra González, Jordi Puig, (unknown), Anna Bonjoch, Patricia Echeverría, Marta Massanella, Eugènia Negredo	1
3	The Effects of Differentiated Organic Fertilization on Tomato Production and Phenolic Content in Traditional and High-Yielding Varieties 2022 ·Antioxidants ·(unknown), Julián Lozano‐Castellón, (unknown), (unknown), Emily P. Laveriano‐Santos, Maria Pérez, Rosa M. Lamuela‐Raventós, Jordi Puig, Anna Vallverdú‐Queralt, Joan Romanyà	6
4	Cybersecurity and Privacy Risk Assessment of Point-of-Care Systems in Healthcare—A Use Case Approach 2021 ·Applied Sciences ·Marc Jofre, Diana Navarro-Llobet, (unknown), Jordi Puig, Gustavo González-Granadillo, (unknown), (unknown)	10
5	COVIDApp as an Innovative Strategy for the Management and Follow-Up of COVID-19 Cases in Long-Term Care Facilities in Catalonia: Implementation Study 2020 ·JMIR Public Health and Surveillance ·Patricia Echeverría, Miquel Àngel Mas, Jordi Puig, (unknown), Mireia Massot Mesquida, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bonaventura Clotet, Eugènia Negredo	37
6	A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV 2020 ·PLoS ONE ·Eugènia Negredo, (unknown), Jordi Puig, Cora Loste, Núria Pérez‐Álvarez, Víctor Urrea, Patricia Echeverría, Anna Bonjoch, Bonaventura Clotet, Julià Blanco	10
7	Colapso traqueal y bronquial en el perro 2019 ·Jordi Puig	0
8	Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery 2017 ·Scientific Reports ·(unknown), Elisabet García, Víctor Urrea, Marta Massanella, Jordi Puig, Eugènia Negredo, Bonaventura Clotet, Julià Blanco, Cecilia Cabrera	12
9	Memory B cell dysregulation in HIV-1-infected individuals 2017 ·AIDS ·Jorge Carrillo, Eugènia Negredo, Jordi Puig, (unknown), Maria Luisa Rodrı́guez de la Concepción, Marta Curriu, Marta Massanella, Jordi Navarro, Manel Crespo, (unknown), Fuensanta Millá, Bonaventura Clotet, Julià Blanco	9
10	In Vivo, Non-Invasive Characterization of Human Bone by Hybrid Broadband (600-1200 nm) Diffuse Optical and Correlation Spectroscopies 2016 ·PLoS ONE ·Sanathana Konugolu Venkata Sekar, Marco Pagliazzi, Eugènia Negredo, Fabrizio Martelli, Andrea Farina, Alberto Dalla Mora, Claus Lindner, Parisa Farzam, Núria Pérez‐Álvarez, Jordi Puig, Paola Taroni, Antonio Pifferi, Turgut Durduran	30
11	Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients 2015 ·AIDS Research and Human Retroviruses ·Eugènia Negredo, Jordi Puig, (unknown), Patricia Echeverría, Anna Bonjoch, Carla Estany, (unknown), (unknown), Bonaventura Clotet	9
12	Polymorphisms in LPL , CETP , and HL Protect HIV-Infected Patients from Atherogenic Dyslipidemia in an Allele-Dose-Dependent Manner 2015 ·AIDS Research and Human Retroviruses ·Montse Guardiola, Patricia Echeverría, Marta Domínguez‐Gil González, Joan-Carles Vallvé, Jordi Puig, Bonaventura Clotet, Josep Ribalta, Eugènia Negredo	5
13	Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery 2015 ·Journal of Translational Medicine ·Marta Massanella, (unknown), Jorge Carrillo, Marta Curriu, Dan Ouchi, Jordi Puig, Eugènia Negredo, Cecilia Cabrera, Bonaventura Clotet, Julià Blanco	26
14	High Prevalence of Signs of Renal Damage Despite Normal Renal Function in a Cohort of HIV-Infected Patients: Evaluation of Associated Factors 2014 ·AIDS Patient Care and STDs ·Anna Bonjoch, Javier Juega, Jordi Puig, Núria Pérez‐Álvarez, (unknown), Patricia Echeverría, (unknown), Bonaventura Clotet, R. Romero, Josep Bonet, Eugènia Negredo	17
15	Peak Bone Mass in Young HIV-Infected Patients Compared With Healthy Controls 2013 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Eugènia Negredo, Peré Domingo, Elena Ferrer, Vicente Estrada, Adrián Curran, (unknown), Valentina Isernia, (unknown), Núria Pérez‐Álvarez, Jordi Puig, Anna Bonjoch, Patricia Echeverría, Daniel Podzamczer, Bonaventura Clotet	25
16	Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment 2012 ·Brain Behavior and Immunity ·Carmina R. Fumaz, Marian González-García, Xavier Borràs, José A. Muñoz-Moreno, Núria Pérez‐Álvarez, Beatriz Mothe, Christian Brander, María José Ferrer, Jordi Puig, Anuska Llano, Jordi Fernández Castro, Bonaventura Clotet	33
17	Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients 2006 ·AIDS Research and Human Retroviruses ·Anna Bonjoch, Roger Paredes, Peré Domingo, Manel Cervantes, Enric Pedrol, Esteban Ribera, Lluís Force, Josep M. Llibre, Josep Vilaró, David Dalmau, (unknown), (unknown), Àngels Masabeu, Núria Pérez‐Álvarez, Jordi Puig, (unknown), Bonaventura Clotet	28
18	Longitudinal Study on Mitochondrial Effects of Didanosine–Tenofovir Combination 2006 ·AIDS Research and Human Retroviruses ·Sònia López, Eugènia Negredo, Glòria Garrabou, Jordi Puig, Lidia Ruíz, (unknown), (unknown), (unknown), Jordi Casademont, Francesc Cardellach, Bonaventura Clotet, Óscar Miró	20
19	Reconstructive Treatment for Antiretroviral-Associated Facial Lipoatrophy: A Prospective Study Comparing Autologous Fat and Synthetic Substances 2006 ·AIDS Patient Care and STDs ·Eugènia Negredo, (unknown), (unknown), Juan Carlos Martínez, Eva Martínez, Jordi Puig, Carmina R. Fumaz, José A. Muñoz-Moreno, Núria Pérez‐Álvarez, Sebastián Videla, Carla Estany, (unknown), (unknown), Bonaventura Clotet	43
20	Lopinavir/Ritonavir Plus Nevirapine as a Nucleoside-Sparing Approach in Antiretroviral-Experienced Patients (NEKA Study) 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Eugènia Negredo, (unknown), David M. Burger, (unknown), (unknown), Josep Ribalta, (unknown), Jordi Puig, Lı́dia Ruiz, Juliana Salazar, (unknown), Julio Montaner, Celestino Rey‐Joly, Bonaventura Clotet	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact